ATE311406T1 - Hemmstoff und stimulator der proliferation haematopoietischer stammzellen und deren anwendungen - Google Patents

Hemmstoff und stimulator der proliferation haematopoietischer stammzellen und deren anwendungen

Info

Publication number
ATE311406T1
ATE311406T1 AT97920117T AT97920117T ATE311406T1 AT E311406 T1 ATE311406 T1 AT E311406T1 AT 97920117 T AT97920117 T AT 97920117T AT 97920117 T AT97920117 T AT 97920117T AT E311406 T1 ATE311406 T1 AT E311406T1
Authority
AT
Austria
Prior art keywords
proliferation
stimulator
inhibitor
applications
stem cells
Prior art date
Application number
AT97920117T
Other languages
English (en)
Inventor
Stephen D Wolpe
Irena Tsyrlova
Original Assignee
Wellstat Therapeutics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellstat Therapeutics Corp filed Critical Wellstat Therapeutics Corp
Application granted granted Critical
Publication of ATE311406T1 publication Critical patent/ATE311406T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT97920117T 1996-04-03 1997-04-03 Hemmstoff und stimulator der proliferation haematopoietischer stammzellen und deren anwendungen ATE311406T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/627,173 US5861483A (en) 1996-04-03 1996-04-03 Inhibitor of stem cell proliferation and uses thereof
PCT/US1997/005601 WO1997036922A1 (en) 1996-04-03 1997-04-03 Inhibitor and stimulator of stem cell proliferation and uses thereof

Publications (1)

Publication Number Publication Date
ATE311406T1 true ATE311406T1 (de) 2005-12-15

Family

ID=24513524

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97920117T ATE311406T1 (de) 1996-04-03 1997-04-03 Hemmstoff und stimulator der proliferation haematopoietischer stammzellen und deren anwendungen

Country Status (16)

Country Link
US (4) US5861483A (de)
EP (2) EP1820805A3 (de)
JP (3) JP4241927B2 (de)
KR (1) KR20040088588A (de)
CN (2) CN1174996C (de)
AT (1) ATE311406T1 (de)
AU (1) AU727023B2 (de)
CA (1) CA2249716A1 (de)
DE (1) DE69734766T2 (de)
ES (1) ES2252781T3 (de)
IL (2) IL126395A0 (de)
NO (1) NO323610B1 (de)
NZ (1) NZ331895A (de)
RU (1) RU2292352C9 (de)
UA (2) UA74128C2 (de)
WO (1) WO1997036922A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT691988E (pt) 1993-03-31 2003-02-28 Wellstat Therapeutics Corp Inibidor da proliferacao de celulas estaminais e suas utilizacoes
US5939391A (en) * 1993-03-31 1999-08-17 Pro-Neuron, Inc. Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
US6610654B2 (en) * 1993-03-31 2003-08-26 Wellstat Therapeutics Corporation Inhibitor of stem cell proliferation and uses thereof
US5861483A (en) 1996-04-03 1999-01-19 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
AUPO089396A0 (en) * 1996-07-09 1996-08-01 Howard Florey Institute Of Experimental Physiology And Medicine Neuroactive peptide
JP2002515880A (ja) * 1996-08-27 2002-05-28 ヘモソル インク． 赤血球造血の増強刺激
DE19708454A1 (de) * 1997-02-17 1998-08-27 Schering Ag Die Proliferation von Zellen inhibierendes Peptid und dessen Verwendung
US8197430B1 (en) * 1998-05-22 2012-06-12 Biopheresis Technologies, Inc. Method and system to remove cytokine inhibitor in patients
US6620382B1 (en) * 1998-05-22 2003-09-16 Biopheresis Technologies, Llc. Method and compositions for treatment of cancers
CA2361608A1 (en) * 1999-02-03 2000-08-10 I.D.M. Immuno-Designed Molecules Cell composition containing macrophages, presenting anti-infectious and hematopoietic properties, and a process for preparing the same
US6379708B1 (en) * 1999-11-20 2002-04-30 Cytologic, Llc Method for enhancing immune responses in mammals
EP1322323A4 (de) 2000-09-11 2004-07-28 Therapro Technologies Inc Thionin als antineoplastisches und immunstimulierendes mittel
EP1387854B1 (de) 2001-01-10 2012-03-21 THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren
SG185137A1 (en) * 2001-07-13 2012-11-29 Cms Peptides Patent Holding Company Ltd Biologically active peptides
CN1210294C (zh) * 2001-07-13 2005-07-13 一泰医药研究（深圳）有限公司 序列号21的生物活性肽
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
RU2245162C2 (ru) * 2003-01-04 2005-01-27 Козлов Владимир Александрович Способ терапии инфаркта миокарда
CA2565215C (en) * 2004-04-30 2014-04-15 Biopheresis Technologies, Inc. Method and system to remove soluble tnfr1, tnfr2, and il2 in patients
FR2872040B1 (fr) * 2004-06-23 2006-09-22 Centre Nat Rech Scient Cnrse Utilisation cosmetique d'au moins un tetrapeptide naturel ac-n-ser-asp-lys-pro- ou un de ses analogues en tant qu'agent antivieillissement et restructurant de la peau
ATE411812T1 (de) * 2004-08-18 2008-11-15 Ipf Pharmaceuticals Gmbh Peptide zur behandlung von infektionen mit dem herpes-virus
US7850960B2 (en) * 2004-12-30 2010-12-14 University Of Washington Methods for regulation of stem cells
KR100621354B1 (ko) * 2005-06-14 2006-09-08 광주과학기술원 유비퀴틴을 이용한 아밀로이드-베타 펩티드의 제조방법
CN101501062B (zh) 2005-07-26 2012-07-18 康哲医药研究(深圳)有限公司 新型生物活性肽及其新用途
US20070065514A1 (en) * 2005-09-22 2007-03-22 Howell Mark D Method for enhancing immune responses in mammals
CN1994464B (zh) * 2005-12-31 2010-05-05 中国科学院大连化学物理研究所 一种血管紧张素i转换酶抑制剂及其应用
RU2317074C1 (ru) * 2006-03-16 2008-02-20 Общество с ограниченной ответственностью "МБФ" Ингибитор дифференцировки кроветворных клеток-предшественников
US20080075690A1 (en) * 2006-09-22 2008-03-27 Mark Douglas Howell Method for enhancing immune responses in mammals
WO2008039874A2 (en) 2006-09-26 2008-04-03 Cedars-Sinai Medical Center Cancer stem cell antigen vaccines and methods
US20110008381A1 (en) * 2007-05-18 2011-01-13 Andrea Keane-Myers Suppression of allergic inflammation by ascaris heme-binding protein (hbp)
US20100204153A1 (en) * 2007-09-11 2010-08-12 Dorian Bevec Use of band 3 protein (824-829) and/or melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infection
CA2710406A1 (en) * 2007-09-11 2009-04-09 Dorian Bevec Use of a peptide as a therapeutic agent
RU2010114039A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Применение октреотида в качестве терапевтического средства
DE602008000891D1 (de) * 2008-04-30 2010-05-12 Immatics Biotechnologies Gmbh Neuartige Formulierungen von Tumor-assoziierten Peptiden, welche an menschliche Leukozytenantigene der Klasse I oder II für Impfungen binden
RU2374262C1 (ru) * 2008-05-22 2009-11-27 Ибмед Холдингс Лимитед Олигопептид, обладающий активностью фактора стволовых клеток csf по отношению к дифференцировке тимоцитов
UA101996C2 (ru) * 2008-11-07 2013-05-27 Юнайтед Технолоджис Ут Аг Соединение, которое содержит интерлейкин-1 и пептид
RU2412708C2 (ru) * 2008-11-27 2011-02-27 Федеральное Государственное Учреждение "Кировский Научно-Исследовательский Институт Гематологии И Переливания Крови Федерального Агентства По Высокотехнологичной Медицинской Помощи" Способ индукции ремиссии у больных приобретенной апластической анемией
US9056085B2 (en) 2009-02-03 2015-06-16 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
WO2010091052A2 (en) 2009-02-03 2010-08-12 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
EA201101639A1 (ru) * 2009-05-20 2012-06-29 Юниверсите Де Женев Ингибиторы митохондриальной активности клеток, инициирующих рак, и их применение
RU2395251C1 (ru) * 2009-05-25 2010-07-27 Государственное образовательное учреждение высшего профессионального образования "Мордовский государственный университет им. Н.П. Огарева" Способ стимулирования миелопоэза животных
US20110070269A1 (en) * 2009-09-24 2011-03-24 Therapro Technologies, Inc. Lipopolysaccharide isolated from pyrularia tissue and/or pyrularia-associated bacteria and uses thereof
RU2452501C2 (ru) * 2010-08-31 2012-06-10 Александр Владимирович Балюра Сенситин для эритроцитарного диагностикума для диагностики злокачественных новообразований и способ его получения, эритроцитарный диагностикум для диагностики злокачественных новообразований и способ его получения и способ диагностики наличия злокачественных новообразований с использованием указанного эритроцитарного диагностикума
EP2649177B1 (de) * 2010-12-08 2018-09-05 ViaCyte, Inc. Mittel und verfahren zur hemmung des wachstums von menschlichen pluripotenten stammzellen
US20140088006A1 (en) * 2011-05-18 2014-03-27 Wellstat Therapeutics Corporation Stem Cell Mobilization and Tissue Repair and Regeneration
US9428552B2 (en) 2012-11-19 2016-08-30 Wellstat Therapeutics Corporation Stem cell mobilization and tissue repair and regeneration
CN103804484B (zh) * 2014-01-24 2016-03-16 南京必优康生物技术有限公司 一种网红细胞生长因子及其制备方法和应用
CN106317177A (zh) * 2015-06-23 2017-01-11 首都医科大学 Gly-Phe-Pro,其合成,活性和应用
CN107899001B (zh) * 2017-05-16 2021-08-06 陈娟娟 Notch配体蛋白在制备治疗肿瘤化疗导致骨髓抑制药物方面及早期预后判断方面的应用
CN109293737B (zh) * 2018-09-27 2020-10-27 华南理工大学 一种抗皮肤衰老的四肽及其用途

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1142466A (en) * 1979-01-09 1983-03-08 Cesar Milstein Cell lines
US4683194A (en) * 1984-05-29 1987-07-28 Cetus Corporation Method for detection of polymorphic restriction sites and nucleic acid sequences
US5132213A (en) * 1986-10-02 1992-07-21 Massachusetts Institute Of Technology Method for producing proteins and polypeptides using ubiquitin fusions
US5196321A (en) 1986-10-02 1993-03-23 Massachusetts Institute Of Technology Methods for in vitro cleavage of ubiquitin fusion proteins
GB8711614D0 (en) * 1987-05-16 1987-06-24 Medical Res Council Proteins
US5449759A (en) * 1987-05-16 1995-09-12 Somatogen, Inc. Hemoglobins with intersubunit desulfide bonds
US5545727A (en) * 1989-05-10 1996-08-13 Somatogen, Inc. DNA encoding fused di-alpha globins and production of pseudotetrameric hemoglobin
EP0700997B1 (de) * 1989-05-10 2003-07-30 Baxter Biotech Technology S.à.r.l. Herstellung von Hämoglobin und Analogen davon in Nicht-Erythrozytzellen
CA2064558C (en) * 1989-09-25 2001-01-30 Ian B. Pragnell Method for inhibiting growth of stem cells
ATE121454T1 (de) 1990-05-09 1995-05-15 Massachusetts Inst Technology Ubiquitinspezifische protease.
US5239061A (en) * 1990-06-20 1993-08-24 Research Corporation Technologies, Inc. Modified human hemoglobin, blood substitutes containing the same, and vectors for expressing the modified hemoglobin
DE69132763D1 (de) * 1990-12-20 2001-11-15 Univ Alabama Res Foundation Bi Transgenes, vernetztes hämoglobin
WO1992020369A1 (en) 1991-05-14 1992-11-26 Dana Farber Cancer Institute Use of hemoglobin in a method for the treatment of tumors with chemotherapeutic agents
US5334706A (en) 1992-01-30 1994-08-02 Baxter International Administration of low dose hemoglobin to increase perfusion
NZ253642A (en) * 1992-06-12 1996-10-28 Dnx Corp Transgenic pig with human globin genes, method of purifying human presbyterian haemoglobin
US5786334A (en) * 1992-08-14 1998-07-28 Technology Resources International, Inc. Hexapeptide having immunostimulatory activity
DE4228458A1 (de) * 1992-08-27 1994-06-01 Beiersdorf Ag Multicistronische Expressionseinheiten und deren Verwendung
PT691988E (pt) 1993-03-31 2003-02-28 Wellstat Therapeutics Corp Inibidor da proliferacao de celulas estaminais e suas utilizacoes
US5939391A (en) * 1993-03-31 1999-08-17 Pro-Neuron, Inc. Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
US6610654B2 (en) * 1993-03-31 2003-08-26 Wellstat Therapeutics Corporation Inhibitor of stem cell proliferation and uses thereof
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
FR2719240B1 (fr) * 1994-04-29 1996-06-07 Elf Antar France Procédé de traitement des suspensions huileuses.
US5861483A (en) 1996-04-03 1999-01-19 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
US6280739B1 (en) * 1996-04-18 2001-08-28 Genetics Institute, Inc. Method of inhibiting angiogenesis using secreted proteins

Also Published As

Publication number Publication date
EP1820805A2 (de) 2007-08-22
US20040167060A1 (en) 2004-08-26
AU727023B2 (en) 2000-11-30
UA85036C2 (ru) 2008-12-25
EP0891377A4 (de) 2003-01-02
EP0891377A1 (de) 1999-01-20
CN1264856C (zh) 2006-07-19
CN1220670A (zh) 1999-06-23
NO323610B1 (no) 2007-06-18
WO1997036922A1 (en) 1997-10-09
US6784155B1 (en) 2004-08-31
DE69734766D1 (de) 2006-01-05
RU2292352C9 (ru) 2007-05-10
KR20040088588A (ko) 2004-10-16
US20060166863A1 (en) 2006-07-27
NO984628D0 (no) 1998-10-02
US5861483A (en) 1999-01-19
NO984628L (no) 1998-12-01
CA2249716A1 (en) 1997-10-09
US7115267B2 (en) 2006-10-03
CN1541706A (zh) 2004-11-03
EP1820805A3 (de) 2007-11-07
JP2000508633A (ja) 2000-07-11
EP0891377B1 (de) 2005-11-30
ES2252781T3 (es) 2006-05-16
UA74128C2 (uk) 2005-11-15
HK1069985A1 (en) 2005-06-10
AU2439197A (en) 1997-10-22
RU2292352C2 (ru) 2007-01-27
DE69734766T2 (de) 2006-09-14
JP2009013178A (ja) 2009-01-22
JP4241927B2 (ja) 2009-03-18
NZ331895A (en) 2000-07-28
JP2012046537A (ja) 2012-03-08
IL126395A0 (en) 1999-05-09
IL176642A0 (en) 2006-10-31
CN1174996C (zh) 2004-11-10

Similar Documents

Publication Publication Date Title
DE69734766D1 (de) Hemmstoff und stimulator der proliferation haematopoietischer stammzellen und deren anwendungen
ES2185649T3 (es) Inhibidores de la proliferacion de las celulas germinales y sus utilizaciones.
ATE263236T1 (de) Inhibitor der stammzellenproliferation und dessen verwendung
SI0750507T1 (en) Proteasome regulation of nf-kappa-b activity
PL331332A1 (en) Cell adhesion inhibitors
IL135068A0 (en) Stimulation of hematopoietic cells in vitro
DE3169744D1 (en) Phosphinylalkanoyl substituted prolines
ATE250571T1 (de) Kaliumkanal-blocker
NO20003600D0 (no) Kaliumkanal inhibitorer
AU6389086A (en) A method for the treatment of atherosclerosis, thrombosis and peripheral vesseldisease
NO902687L (no) Merkaptoacylaminosyre-antihypertensjonsmidler.
ES8205126A1 (es) Un procedimiento para la preparacion de un inhibidor del enzima convertidor de la angiotensina.
GEP20012440B (en) Biphenylsulfonamide Matrix Metalloproteinase Inhibitors

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0891377

Country of ref document: EP

REN Ceased due to non-payment of the annual fee